D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

BACKGROUND: Over 5,488,000 cases of coronavirus disease-19 (COVID-19) have been reported since December 2019. We aim to explore risk factors associated with mortality in COVID-19 patients and assess the use of D-dimer as a biomarker for disease severity and clinical outcome. METHODS: We retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yumeng, Cao, Jiatian, Wang, Qingqing, Shi, Qingfeng, Liu, Kai, Luo, Zhe, Chen, Xiang, Chen, Sisi, Yu, Kaihuan, Huang, Zheyong, Hu, Bijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348129/
https://www.ncbi.nlm.nih.gov/pubmed/32665858
http://dx.doi.org/10.1186/s40560-020-00466-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348129/
https://www.ncbi.nlm.nih.gov/pubmed/32665858
http://dx.doi.org/10.1186/s40560-020-00466-z

Ejemplares similares